A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Insulin glulisine
Calcium gluconate
The serum concentration of Dolutegravir can be decreased when it is combined with Calcium gluconate.
Insulin glulisine
Calcium citrate
The serum concentration of Dolutegravir can be decreased when it is combined with Calcium citrate.
Insulin glulisine
Calcium carbonate
The serum concentration of Dolutegravir can be decreased when it is combined with Calcium carbonate.
Insulin glulisine
Calcium
The serum concentration of Dolutegravir can be decreased when it is combined with Calcium.
Insulin detemir
Lithium hydroxide
The risk or severity of serotonin syndrome can be increased when Levomilnacipran is combined with Lithium hydroxide.
Insulin detemir
Lithium citrate
The risk or severity of serotonin syndrome can be increased when Lithium citrate is combined with Levomilnacipran.
Insulin detemir
Lithium carbonate
The risk or severity of serotonin syndrome can be increased when Levomilnacipran is combined with Lithium carbonate.
Insulin detemir
Satralizumab
The serum concentration of Levomilnacipran can be decreased when it is combined with Satralizumab.
Insulin detemir
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Levomilnacipran is combined with Oliceridine.
Insulin detemir
Abametapir
The serum concentration of Levomilnacipran can be increased when it is combined with Abametapir.
Insulin detemir
Selpercatinib
The serum concentration of Levomilnacipran can be increased when it is combined with Selpercatinib.
Insulin detemir
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Levomilnacipran.
Insulin detemir
Cenobamate
The serum concentration of Levomilnacipran can be decreased when it is combined with Cenobamate.
Insulin detemir
Givosiran
The serum concentration of Levomilnacipran can be increased when it is combined with Givosiran.
Insulin detemir
Lasmiditan
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Levomilnacipran.
Insulin detemir
Solriamfetol
The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Levomilnacipran.
Insulin detemir
Esketamine
The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Esketamine.
Insulin detemir
Mefenorex
The risk or severity of Tachycardia can be increased when Levomilnacipran is combined with Mefenorex.
Insulin detemir
Fenozolone
The risk or severity of Tachycardia can be increased when Levomilnacipran is combined with Fenozolone.
Insulin detemir
Tramazoline
The risk or severity of Tachycardia can be increased when Levomilnacipran is combined with Tramazoline.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3